Abrax Japan, Inc. is a biotech company that harnesses the potential of an immune modulating protein called thymic stromal lymphopoietin (TSLP) for the treatment of multiple disorders including eczema, dry eye disease, obesity, obesity-related metabolic complications.
This is some text inside of a div block.
